RxDoctor Payments Data

Verna Burdett

Psychiatry · Woodbridge, VANPI 1821168212

Payments from drug & device makers

$5,991in general payments, 2019–2025

Across 264 payments — averaging $22.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$868
  • Otsuka America Pharmaceutical, Inc.$842
  • Sunovion Pharmaceuticals Inc.$529
  • Lundbeck LLC$502
  • Tris Pharma Inc$414
  • Johnson & Johnson$409
  • plus $2K from 15 others

What the payments were for

  • Food & beverage$5,979100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,991 in reported general payments places this provider in the 90th percentile of 884 psychiatry providers in Virginia.

See all psychiatry providers in Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole11$17,494
Paliperidone ErPaliperidone22$2,145
Aripiprazole53$1,629
Desvenlafaxine Succinate ErDesvenlafaxine Succinate16$1,605
Buspirone Hcl17$859
Escitalopram Oxalate74$596
Ramelteon13$583
Fluoxetine Hcl41$541
Clonazepam49$437
Quetiapine Fumarate34$397
Olanzapine16$348
Venlafaxine Hcl ErVenlafaxine Hcl19$303
Lamotrigine12$212
Alprazolam27$164
Trazodone Hcl30$161

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$842$17,49411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 884 psychiatry providers in Virginia.

Other psychiatry in Woodbridge

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →